https://www.theedgemarkets.com/article/astrazeneca-says-its-antibody-treatment-failed-preventing-covid19-exposed-patients
0
0
58 words
0
Comments
BENGALURU (June 15): Anglo-Swedish drug maker AstraZeneca said on Tuesday a study of its monoclonal antibody treatment, AZD7442, did not meet the main goal of preventing symptomatic Covid-19 in people recently exposed to the novel coronavirus.The company said…
You are the first to view
Create an account or login to join the discussion